Predicted HIV-1 coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic

Predicted HIV-1 coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic

<p>Abstract</p> <p>Background</p> <p>CCR5 antagonists have clinically been approved for prevention or treatment of HIV/AIDS. Countries in Sub-Saharan Africa with the highest burden of HIV/AIDS are due to adopt these regimens. However, HIV-1 can also use CXCR4 as a co-re...

Full description

Bibliographic Details
Main Authors: Wambui Veronica, Kiptoo Michael, Kinyua Joyceline, Odera Irene, Muge Edward, Muiruri Peter, Lihana Raphael, Kinyanjui Peter, Songok Elijah M
Format: Article
Language:English
Published: BMC 2012-07-01
Series:AIDS Research and Therapy
Subjects:
Co-receptor usage
HIV-1
Sub-type D
Online Access:http://www.aidsrestherapy.com/content/9/1/22

Internet

http://www.aidsrestherapy.com/content/9/1/22

Similar Items